Vor Bio宣布管理层将参加9月多场投资者会议

BOSTON, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that management will participate in the following investor conferences:
Wells Fargo 21st Annual Healthcare Conference
Forum: Fireside Chat and 1x1 Meetings
Date: Tuesday, September 8th
Presentation Time: 8:00AM ET
Citi’s 2026 Biopharma Back to School Conference
Forum: Fireside Chat and 1x1 Meetings
Date: Wednesday, September 9th
Presentation Time: 11:20AM ET
Morgan Stanley 24th Annual Global Healthcare Conference
Forum: 1x1 Meetings
Date: Monday, September 14th
Baird’s 2026 Global Healthcare Conference
Forum: Presentation and 1x1 Meetings
Date: Tuesday, September 15th
Presentation Time: 9:05AM ET
Stifel’s 2026 Virtual Immunology and Inflammation Forum
Forum: Presentation and 1x1 Meetings
Date: Wednesday, September 23rd
Presentation Time: 11:30AM ET
A live webcast of the presentation may be accessed on the Investors section of the Vor website at ir.vorbio.com. A replay of the webcast will be available on the Vor website for approximately 30 days following the presentation.
About Vor Bio
Vor Bio is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. The Company is focused on rapidly advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and potential commercialization to address serious autoantibody-driven conditions worldwide. For more information visit
www.vorbio.com
. Vor Bio routinely posts information that may be important to investors in the “Investors” section of its website. The Company encourages investors to consult that section of its website regularly.